Results 241 to 250 of about 12,260,572 (400)
Current and novel biomarkers in cardiogenic shock
A summary of current and novel biomarkers and their potential stages of release in cardiogenic shock. The diagram illustrates the proposed release of the biomarkers during the different stages of cardiogenic shock: progression from cardiac dysfunction/stress, through to inflammation and end‐organ dysfunction.
Victor Galusko+5 more
wiley +1 more source
Sometimes the easiest way is the best. Simple methods as ST‐segment elevation in III > II and ST‐segment depression in aVL > I are effective diagnostic test for identifying culprit artery in inferior wall ST‐segment elevation myocardial infarction. Complex algorithms are not superior to simple methods.
Peng Zhou+9 more
wiley +1 more source
Troponin‐T: improved diagnostic assessment of myocardial damage in childhood [PDF]
FF Immer+5 more
openalex +1 more source
End‐organ protective effect of serelaxin in patients with acute heart failure. CV, cardiovascular; HF, heart failure; NT‐proBNP, N‐terminal pro‐B‐type natriuretic peptide. Abstract Aims Serelaxin is recombinant human relaxin‐2, a hormone responsible for haemodynamic adaptations and organ protection in pregnancy.
Adriaan A. Voors+12 more
wiley +1 more source
Skeletal muscle and subcutaneous fat quantity as prognostic indicators in cardiac amyloidosis
Aims Disease‐related changes in body composition are associated with worse outcomes in chronic heart failure. In cardiac amyloidosis (CA), the prognostic value of direct body composition measures is understudied. Methods and results We identified 160 consecutive patients with CA (transthyretin [ATTR] or light chain [AL]) diagnosed between 2001 and 2021
Joshua Longinow+4 more
wiley +1 more source
Cardiac troponin T and I: back to basics. [PDF]
Mingels AM, Mills NL, Mueller C.
europepmc +1 more source
Non-invasive diagnosis of infarct artery patency after acute myocardial infarction by use of serial plasma troponin T concentrations: importance of measurement of peak levels. [PDF]
R M Norris+3 more
openalex +1 more source
Abstract This clinical consensus statement revisits the role of left ventricular ejection fraction (LVEF) as a measurement of cardiac function, a prognostic marker and a major criterion to classify patients with heart failure, and gives new advice for clinical practice.
Giuseppe M.C. Rosano+20 more
wiley +1 more source
Risk stratification with a point-of-care cardiac troponin T test in acute myocardial infarction [PDF]
E. Magnus Ohman+10 more
openalex +1 more source